CDH1 and cancer: Our analysis is based on three premises: 1) Cancer-relevant miRNAs act in pathways that regulate cellular differentiation stages which can be recognized by the signature of expression of a number of stage-specific marker genes (i.e. E-cadherin for epithelial cells or early carcinomas).